Advances in Surgical and Medical Specialties (Hardcover)

The pace and sophistication of advances in medicine in the past two decades have been truly breathtaking. This has necessitated a growing need for comprehensive references that highlight the current issues in specific sectors of medicine. Keeping this in mind, each volume in the Current Issues in Medicine series is a stand‐alone text that provides a broad survey of various critical topics in a focused area of medicine―all accomplished in a user-friendly yet interconnected format. However, unlike other series on medicine or medical texts, this series focuses on current trends, perspectives, and issues in medicine that are central to healthcare delivery in the 21st century. Medical practitioners today continue to improve upon techniques and technologies to provide procedures for patients that are safer, faster, less invasive, and more accurate ―a direct consequence of advances in technological breakthroughs from a variety of medical and engineering fields. In order to render modern patient care, it is imperative that surgeons and medical practitioners stay current with these latest advances in their respective specialties. Given this backdrop, the specific topics covered in this volume and the expertise of the contributing authors accurately reflect the rapidly evolving areas within surgical and medical specialties. While recognising how expansive and multifaceted medicine is, Advances in Surgical and Medical Specialties addresses crucial recent advances in surgical and medical specialties, intergrating the knowledge and experience of experts from academia and practicing surgeons. The multidisciplinary approach reflected here makes this volume a valuable reference resource for medical practictioners, medical students, nurses, fellows, residents, undergraduate and graduate students, educators, venture capitalists, policymakers, and biomedical researchers. A wide audience will benefit from having this volume on their bookshelf: health care systems, the pharmaceutical industry, academia, and government.

Raj Bawa, PhD, MD, is president of Bawa Biotech LLC (founded in 2002), a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia, USA. Trained as a microbiologist and biochemist, he is an inventor, author, entrepreneur, professor, and registered patent agent (since 2002) licensed to practice before the US Patent & Trademark Office. He is currently a scientific advisor to Teva Pharmaceutical Industries, Israel (since 2010), and full professor (adjunct) at Northern Virginia Community College, Annandale, Virginia (since 2004). He is vice president and chief IP officer at Guanine, Inc., Rensselaer, New York (since 2017), a company focused on rapid, accurate detection of infective pathogens. He has served as a principal investigator of various National Cancer Institute (NCI) research grants; most recently as a principal investigator of a Centers for Disease Control and Prevention (CDC) grant to develop an assay for Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. He was an adjunct professor at Rensselaer Polytechnic Institute, Troy, New York, from 1998 to 2018. After earning a BSc (Honors School) in microbiology, he earned an MS in cancer biology, a PhD in biophysics/biochemistry, and an MD. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner from 1996–2002. Currently, he is a life member of Sigma Xi, cochair of the nanotech and precision medicine committees of the American Bar Association, and founding director of the American Society for Nanomedicine (established in 2008). He has authored over 100 publications, edited 10 texts, and serves on the editorial boards of numerous peer-reviewed journals, including serving as an associate editor of Nanomedicine (Elsevier).